Corneal Diseases  >>  ozagrel ophthalmic (KCT-0809)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
NCT01211951: A Study of KCT-0809 in Patients With Dry Eye Syndromes

Completed
2
160
Japan
KCT-0809, Placebo
Kissei Pharmaceutical Co., Ltd.
Dry Eye Syndromes
 
 
NCT01427816: A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

Completed
2
180
Japan
KCT-0809, Placebo
Kissei Pharmaceutical Co., Ltd.
Dry Eye Syndromes
 
 
NCT01890941: A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Completed
2
Japan
KCT-0809 ophthalmic solution, Placebo
Kissei Pharmaceutical Co., Ltd.
Dry Eye Syndromes
03/14
 
NCT01692145: A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Completed
2
Japan
KCT-0809, Placebo
Kissei Pharmaceutical Co., Ltd.
Dry Eye Syndromes
 
 

Download Options